Teresa Battista

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 23

Top Topics

Hidradenitis Suppurativa

Top Venues

Clinical and experimental dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Journal of cosmetic dermatology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Fabrizio Martora, Luca Potestio, Teresa Battista, Matteo Megna
Reply to "Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa". Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Fabrizio Martora, Luca Potestio, Teresa Battista, Matteo Megna
Reply to "Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa". Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Fabrizio Martora, Matteo Megna, Teresa Battista, Massimiliano Scalvenzi, Alessia Villani, Sara Cacciapuoti, Luca Potestio
Viral reactivation following COVID-19 vaccination: a review of the current literature. Clinical and experimental dermatology 49 (6) (2024)
Teresa Battista, Lucia Gallo, Fabrizio Martora, Davide Fattore, Luca Potestio, Sara Cacciapuoti, Massimiliano Scalvenzi, Matteo Megna
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study. Journal of clinical medicine 13 (7) (2024)
Fabrizio Martora, Luca Potestio, Teresa Battista, Matteo Megna
Reply to "Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa". Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Teresa Battista, Lucia Gallo, Fabrizio Martora, Davide Fattore, Luca Potestio, Sara Cacciapuoti, Massimiliano Scalvenzi, Matteo Megna
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study. Journal of clinical medicine 13 (7) (2024)
Teresa Battista, Lucia Gallo, Fabrizio Martora, Davide Fattore, Luca Potestio, Sara Cacciapuoti, Massimiliano Scalvenzi, Matteo Megna
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study. Journal of clinical medicine 13 (7) (2024)
Fabrizio Martora, Matteo Megna, Teresa Battista, Massimiliano Scalvenzi, Alessia Villani, Sara Cacciapuoti, Luca Potestio
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature. Clinical and experimental dermatology (2024)
Luca Potestio, Fabrizio Martora, Alessia Villani, Sara Cacciapuoti, Teresa Battista, Matteo Megna
Advancing Dermatology: Embracing the Power of Artificial Intelligence. Clinical and experimental dermatology (2023)
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, Luca Potestio
Comment on 'Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination'. Clinical and experimental dermatology 48 (1) (2023)
Luca Potestio, Lucia Genco, Matteo Noto, Gabriella Fabbrocini, Teresa Battista, Fabrizio Martora
Comment on 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'. Clinical and experimental dermatology 48 (1) (2023)
Luca Potestio, Lucia Genco, Teresa Battista, Matteo Noto, Gabriella Fabbrocini, Fabrizio Martora
Comment on 'Anogenital dermatology: challenges in the digital era'. Clinical and experimental dermatology 48 (1) (2023)
Fabrizio Martora, Ruggiero Angelo, Teresa Battista, Luca Potestio, Matteo Megna
Comment on: "Associations between hidradenitis suppurativa and dermatological conditions in adults: A national cross-sectional study by Brown et al." Clinical and experimental dermatology (2023)
Luca Potestio, Lucia Genco, Teresa Battista, Matteo Noto, Gabriella Fabbrocini, Fabrizio Martora
Comment on 'Anogenital dermatology: challenges in the digital era'. Clinical and experimental dermatology 48 (1) (2023)
Fabrizio Martora, Gabriella Fabbrocini, Claudio Marasca, Teresa Battista, Matteo Megna
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a psoriasis patient. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab". Clinical and experimental dermatology (2023)
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, Luca Potestio
Comment on 'Eosinophilic pustular folliculitis developing at the site of COVID-19 vaccination'. Clinical and experimental dermatology 48 (1) (2023)
Fabrizio Martora, Ruggiero Angelo, Luca Potestio, Teresa Battista, Matteo Megna
Reply to "Dalbavancin for the treatment of severe hidradenitis suppurativa". Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Fabrizio Martora, Teresa Battista, Luca Potestio, Massimiliano Scalvenzi, Paola Nappa, Matteo Megna
Reply to "Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease" by Gambichler et al. Clinical and experimental dermatology (2023)
Luca Potestio, Lucia Genco, Matteo Noto, Gabriella Fabbrocini, Teresa Battista, Fabrizio Martora
Comment on 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'. Clinical and experimental dermatology 48 (1) (2023)
Fabrizio Martora, Alessia Villani, Teresa Battista, Gabriella Fabbrocini, Luca Potestio
COVID-19 vaccination and inflammatory skin diseases. Journal of cosmetic dermatology (2022)
Fabrizio Martora, Alessia Villani, Gabriella Fabbrocini, Teresa Battista
COVID-19 and cutaneous manifestations: A review of the published literature. Journal of cosmetic dermatology (2022)
Matteo Megna, Teresa Battista, Luca Potestio, Ruggiero Angelo, Virginia Ventura, Gabriella Fabbrocini, Vincenzo Picone
A case of erythrodermic psoriasis rapidly and successfully treated with Bimekizumab. Journal of cosmetic dermatology (2022)
Teresa Battista, Gabriella Fabbrocini, Lorenzo Martora, Fabrizio Martora
Atypical case of cutaneous Rosai-Dorfman disease. Journal of cosmetic dermatology (2022)